Innovating Works

BASECLICK GMBH

Desconocido
NATURE-ETN: Nucleic Acids for Future Gene Editing Immunotherapy and Epigenetic Sequence Modification BASECLICK GMBH participó en un H2020: H2020-MSCA-ITN-2019 Nucleic acid (NAs) therapies are predicted to yield major advances in the treatment of human disease and new approaches in NA design are req...
2020-02-05 - 2024-09-30 | Financiado
LightDyNAmics: DNA as a training platform for photodynamic processes in soft materials BASECLICK GMBH participó en un H2020: H2020-MSCA-ITN-2017 Light interaction with biomaterials is the driving mechanism of fundamental biological processes, from photosynthesis to DNA photodamage, an...
2017-08-29 - 2022-10-31 | Financiado
DNA-Robotics: DNA Based Modular Nanorobotics BASECLICK GMBH participó en un H2020: H2020-MSCA-ITN-2017 Robotic systems essentially comprise sensors and actuators connected to and coordinated by an information-processing unit. These principles...
2017-08-29 - 2022-06-30 | Financiado
ClickGene: Click Chemistry for Future Gene Therapies to Benefit Citizens Researchers and Industry BASECLICK GMBH participó en un H2020: H2020-MSCA-ITN-2014 Gene therapy is expected to play a key role in next-generation medicine by correcting the underlying genetic causes of disease, thereby faci...
2014-12-05 - 2018-12-31 | Financiado
ESCODNA: European School of DNA Nanotechnology BASECLICK GMBH participó en un FP7: DNA Nanotechnology is an emerging interdisciplinary area that will underpin the development of future nanoscience-based technologies for are...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.